Searching for the biological consequences of detected HLA-C*04:01 association with clinical manifestation, we tested a possible contribution of this allele to the HLA class I heterozygosity and number of SARS-CoV-2 peptides presenting ability, which reportedly are protective against progression of COVID-19 (31). This evidence concerns the gene HLA-C and COVID-19.